: Synthesis procedure Compound 1: Ethyl 4-(4-formyl-3-methoxy)-phenyl butyrate dimethyl acetal [1] 400 mg was mixed with tris(2-aminoethyl)amine 1.5 ml. This mixture was stirred at 100 ºC under nitrogen atmosphere for 24 h. After reaction, tris(2-aminoethyl)amine was removed by distilling at 100 º C under high vacuum. Yellow oil raw product was further purified by basic aluminum oxide column chromatography (elution: CH2Cl2/ N (CH3CH2)3 = 95/5). 1 Compound 2: An aqueous solution of 1.0 g dextran (70 kDa; 12.5% (w/v); pH 5.5) was oxidized with 2 mL of sodium periodate solution (20 mg/mL) at room temperature for 4 h to yield theoretical oxidations of 3%. Here the oxidation degree (OD) is defined as the number of oxidized residues per 100 glucose residues). The oxidized dextran was purified through centrifugal filter tubes (Amicon ultra-15, 10,000 MW cutoff) for 3 times (10 minutes per time). The solution was lyophilized to produce the white solid oxidized dextran. Due to the very low OD, the oxidized residues were difficult to identify by NMR. The actual oxidation degree determined by TNBS colorimetric titration assay was 3.1 ± 0.2%. [2] 100 mg oxidized dextran was dissolved in 2. 
Determination of size distribution and zeta potential of compound 4 and siRNA/compound 4 nanoplex
The hydrodynamic radius and size distribution of compound 4 were determined by dynamic light scattering (DLS, 10 mW He-Ne laser, 633 nm wavelength). Dextran-siRNA nanoplex for size distribution measurement was prepared at N/P ratios of 15 by adding compound 4 in 600 μl PBS pH=7.4 buffer to a solution of siRNA (400 μl, in DI waters, 50 μg/ml), followed by vortexing for 10 s and incubating for 20 min at room temperature. The DLS measurements were performed in triplicate. Dextran-siRNA nanoplex (N/P = 15) for measurement of zeta potential was prepared by adding compound 4 in 600 μl DI water to a solution of siRNA (400 μL, in DI waters, 50 μg/ml), 
N/P value dependent stability of siRNA/compound 4 nanoplex
The N/P ratio is crucial for determining the stability and delivery efficacy of the polymer/siRNA nanoplex. Electrophoretic gel mobility shift assay was used to evaluate the N/P ratio between compound 4 and COX-2 siRNA. Compound 4 and COX-2 siRNA were mixed in PBS (pH = 7.4) buffer with N/P values of 0, 1, 5, 10, and 15. After 30 min incubation at room temperature, the resulting nanoplexes were loaded on a 5% agarose gel (1.0 μg COX-2 siRNA per well). After electrophoresis, the nucleotide was stained by ethidium bromide and UV light images were obtained. 
Degradation of compound 4
Compound 4 was incubated in pH 5.5 buffer for 8 h, after which the pH value was changed to pH 7.4 by adding NH3·H2O. After dialysis in pH 7.4 NH3·H2O solution, partially degraded compound 4 solid was collected by lyophilization. This solid was dissolved in D2O for 1 H NMR spectroscopy, or dissolved in PBS pH7.4 buffer for gel permeation chromatography (GPC).
Figure S4:
1 H NMR spectra of compound 4 before and after incubation in pH 5.5 buffer. The intensity of peaks was normalized to the peak of dextran at 4.9 ppm.
Figure S5:
The effluent peak of dextran and compound 4 before and after incubation in pH 5.5
buffer.
Determination of Cytotoxicity of Compound 4 in vitro
The concentration dependent cytotoxicities of compound 4 in MDA-MB-231 human breast cancer cells and human mammary fibroblasts after 3 days incubation were measured using an MTT assay.
As demonstrated in Figure S6 , compound 4 did not show toxicity up to 3 days incubation with concentrations up to 100 g/ml. 
